Luma Group

Emerging manager

SEC exempt reporting adviser (venture capital exemption).

Website: https://www.lumagroup.com
HQ: NY

Luma Group is a multistage investment firm focused on biotechnology. It combines scientific insight and computation in its investment strategy and backs teams turning breakthrough science into therapies, diagnostics, and medical devices. The team includes a founder and managing member, co-founders and partners, a head of research, and a chief financial officer. Portfolio companies named on the site include Aeovian Pharmaceuticals and Coultreon Bio.

01 · Says / Does

Tag	Says	Does
Stages	Not stated	Not enough dated deals
Sectors	Biotech	Not enough dated deals
Regions	Not stated	Not enough dated deals

Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.

02 · Fund history

Fund	Year	Size	Status
LumaBio I LP Luma Group is a multistage investment firm focused on biotechnology. It backs teams translating breakthrough science into therapies, diagnostics, and medical devices, combining scientific insight and computation. Inferred from the firm's website	2023	$410M (Form D)	Open, writing first checks

03 · People across funds

Joshua Fink, Founder and Managing Member of Adviser
LumaBio I LP (Named on Form D)
Thenasap Kahn, Partner and Co-Founder
LumaBio I LP (Named on Form D)
William Ryan, Chief Financial Officer
LumaBio I LP (Named on Form D)
Bill Ryan, Chief Financial Officer
LumaBio I LP (Team)
Jamie Kasuboski, PhD, Partner & Head of Research
LumaBio I LP (Team)
John Gomez, Senior Associate
LumaBio I LP (Team)
Josh Fink, Founder & Managing Member
LumaBio I LP (Team)
Negin Mokhtari, PhD, Venture Partner & Chief Strategy Officer of LABI
LumaBio I LP (Team)
Rosana Kapeller, MD, PhD, Venture Partner
LumaBio I LP (Team)
Themasap Khan, PhD, Co-Founder & Partner
LumaBio I LP (Team)

04 · Recent deals

No dated deals found yet.

05 · Latest from the firm

No news from the firm's website yet.

06 · Sources

Fund dates and sizes are from SEC Form D filings.

Last verified: Oct 28, 2026